Rethinking Cefepime Neurotoxicity: An Integrated PK–Neuromonitoring Approach for Neurocritical Care
Helena Barrasa, Thiago H. G. Silva, Ana Alarcia-Lacalle, Ana Tejero, Amaia Quintano · 2026
Read Rethinking Cefepime Neurotoxicity: An Integrated PK–Neuromonitoring Approach for Neurocritical Care by Helena Barrasa, Thiago H. G. Silva, Ana Alarcia-Lacalle, Ana Tejero, Amaia Quintano (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13642506.txt.
Description
Helena Barrasa and colleagues propose a 2026 viewpoint for catching the drug's brain side effects earlier in brain critical care, where the antibiotic's brain side effects remain under-recognized. The drug is widely used for its broad coverage and brain penetration. Toxicity often appears as shifting confusion, inattention, muscle jerks, or speech trouble within days, easily mistaken for sepsis or underlying brain injury. Because sedation and critical illness hide early signs, the drug is often continued too long, delaying the most effective step, stopping it.
The authors argue toxicity is largely exposure-driven and therefore preventable, with risk raised by unstable kidney function, prior brain disease, white-matter change, older age, higher weight, and other health problems. Their framework pairs early spotting of at-risk patients with simple brain monitoring and timely drug-level testing to spot harmful exposure before severe confusion or silent seizures develop.
Catalog record
| CREATOR | Helena Barrasa, Thiago H. G. Silva, Ana Alarcia-Lacalle, Ana Tejero, Amaia Quintano |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |